Related Experiment Video
Updated: Jun 10, 2026
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Hot flushes: are there effective alternatives to estrogen?
Jenifer Sassarini1, Mary Ann Lumsden
1University of Glasgow, Department of Developmental Medicine, Glasgow, UK. j.sassarini.1@research.gla.ac.uk
Menopause International
|August 24, 2010
Summary
Hormone replacement therapy (HRT) effectively treats hot flushes, but safety concerns have led many women to stop. Developing non-hormonal alternatives is challenging due to limited understanding of hot flush causes.
Area of Science:
- Menopause research
- Women's health
- Endocrinology
Background:
- Hot flushes are a primary reason for prescribing hormone replacement therapy (HRT).
- Estrogen therapy is highly effective for managing hot flushes, with over 80% efficacy.
- Widespread HRT use declined significantly after safety concerns arose from studies like the Women's Health Initiative (WHI).
Purpose of the Study:
- To review the impact of HRT discontinuation on hot flush recurrence.
- To assess the effectiveness of current alternatives to HRT for hot flushes.
- To highlight the challenges in developing novel non-hormonal treatments for hot flushing.
Main Methods:
- Review of publications regarding HRT use and discontinuation.
- Analysis of patient-reported outcomes following HRT cessation.
- Assessment of the efficacy of available non-estrogen treatments for hot flushes.
Main Results:
- A significant number of women discontinued HRT due to safety concerns.
- Many women experienced a recurrence of hot flushes after stopping HRT.
- Only a small percentage of women restarted HRT, primarily due to severe symptoms, and few effective non-hormonal alternatives exist.
Conclusions:
- Estrogen remains the most effective treatment for hot flushes, despite safety concerns.
- Limited understanding of hot flush mechanisms hinders the development of effective non-hormonal therapies.
- Further research into the aetiology of hot flushing is crucial for advancing treatment options.
Related Concept Videos
01:28Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
01:22Methods of reducing fever
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:22Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.